A majority of Supreme Court justices appeared skeptical Tuesday of the idea of a nationwide ban or new limits on mifepristone ...
The FDA and some health care groups had been worried that limits on the chemical could disrupt the medical supply chain.
At issue in the case are lower-court rulings that would have rolled back recent Food and Drug Administration decisions to ease access to ... from the agency’s regulations.
The justices considered a challenge to the Food and Drug Administration ... mifepristone regulations brought by a group of anti-abortion doctors -- suggesting recent steps to ease access to ...
The FDA indicated that the decision to separate the finalized versions of the 2016 draft guidance into discrete sections for ease of use is responsive to ... the NDI is considered to be adulterated.
Mifepristone, the first pill taken in a two-drug regimen for a medication ... lawmakers and judges to support more restrictions or, on the other hand, ease pathways to obtaining abortion and ...
The Oregon Health Authority launched a website to make it easier for women to access an abortion on Tuesday, the same day the U.S. Supreme Court considered another abortion case brought by groups ...
In nearly 90 minutes of arguments, a consensus appeared to emerge that the abortion opponents who challenged the FDA’s approval of the medication, mifepristone, and subsequent actions to ease ...
"If this medication is restricted or banned completely, no one will be able to get access to it with any ease," she says ... regardless of state restrictions.) 6. The drug industry could face ...
In nearly 90 minutes of arguments, a consensus appeared to emerge that the abortion opponents who challenged the FDA’s approval of the medication, mifepristone, and subsequent actions to ease ...
The law also includes tougher punishments for offenses such as illegal firearms and retail theft and eases some restrictions on police to target suspected criminals. Implementing drug-free zones ...